HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effect of nicotinamide against poly(ADP-ribose) polymerase-1-mediated astrocyte death depends on its transporter-mediated uptake.

AbstractAIM:
Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA repair enzyme, and its excessive activation, following ischemia, trauma, etc., depletes cellular nicotinamide adenine dinucleotide (NAD(+)) as a substrate and eventually leads to brain cell death. Nicotinamide, an NAD(+) precursor and a PARP-1 inhibitor, is known to prevent PARP-1-triggered cell death, but there is no available information on the mechanisms involved in its transport. Here we clarified the transport characteristics of nicotinamide in primary cultured mouse astrocytes.
MAIN METHODS:
Uptake characteristics of [(14)C]nicotinamide were assessed by a conventional method with primary cultured mouse astrocytes. Cell viability and PARP-1 activity were determined with intracellular LDH activity and immunocytochemical detection of PAR accumulation, respectively.
KEY FINDINGS:
PARP-1 activation was induced by treatment of astrocytes with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), an alkylating agent. MNNG-triggered astrocyte death and PAR accumulation were completely inhibited by treatment with nicotinamide as with DPQ (3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone), a second generation PARP inhibitor. The uptake of [(14)C]nicotinamide was time-, temperature-, concentration- and pH-dependent, and was inhibited and stimulated by co- and pre-treatment with N-methylnicotinamide, a representative substrate of an organic cation transport system, respectively. Co-treatment of astrocytes with nicotinamide and N-methylnicotinamide resulted in a decrease in PAR accumulation and absolute prevention of cell death.
SIGNIFICANCE:
These findings suggest that nicotinamide has a protective effect against PARP-1-induced astrocyte death and that its transporter-mediated uptake, which is extracellular pH-sensitive and common to N-methylnicotinamide, is critical for prevention of PARP-1-triggered cell death.
AuthorsEri Suzuki, Hiroto Okuda, Kentaro Nishida, Sadaki Fujimoto, Kazuki Nagasawa
JournalLife sciences (Life Sci) Vol. 86 Issue 17-18 Pg. 676-82 (Apr 24 2010) ISSN: 1879-0631 [Electronic] Netherlands
PMID20188745 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Vitamin B Complex
  • Niacinamide
  • Parp1 protein, mouse
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases
  • N-methylnicotinamide
Topics
  • Animals
  • Astrocytes (drug effects, metabolism)
  • Biological Transport
  • Cell Death (drug effects)
  • Cell Survival (drug effects)
  • Hydrogen-Ion Concentration
  • Mice
  • Niacinamide (analogs & derivatives, pharmacokinetics, pharmacology)
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases (metabolism)
  • Temperature
  • Time Factors
  • Vitamin B Complex (pharmacokinetics, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: